Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Bupropion

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 62Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of October 29, 2025
    Enforcement Report - Week of October 29, 2025

    29 Oct 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-29-2025-82388.pdf

    FDA
    29 Oct 2025
    Share Share
    Annora`s Generics Bupropion Hydrochloride Receives Approval in US
    Annora`s Generics Bupropion Hydrochloride Receives Approval in US

    01 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217898

    FDA
    01 Oct 2025
    Share Share
    Currax Study In Obesity Pillars Supports CONTRAVE/MYSIMBA CV Safety
    Currax Study In Obesity Pillars Supports CONTRAVE/MYSIMBA CV Safety

    11 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/currax-pharmaceuticals-peer-reviewed-study-in-obesity-pillars-further-substantiates-cardiovascular-safety-profile-of-contravemysimba-302397897.html

    PR NEWSWIRE
    11 Mar 2025
    Share Share
    Axsome FDA Pre-NDA Minutes Support AXS-05 Filing In AD Agitation
    Axsome FDA Pre-NDA Minutes Support AXS-05 Filing In AD Agitation

    03 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/03/3035463/33090/en/Axsome-Therapeutics-Announces-FDA-Pre-NDA-Meeting-Minutes-for-AXS-05-in-Alzheimer-s-Disease-Agitation-Supporting-NDA-Submission.html

    GLOBENEWSWIRE
    03 Mar 2025
    Share Share
    Currax Provides Update on Litigation Against Found Health
    Currax Provides Update on Litigation Against Found Health

    25 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/currax-provides-update-on-litigation-against-found-health-inc-302384351.html

    PR NEWSWIRE
    25 Feb 2025
    Share Share
    Teva agrees with Axsome to keep generic off market until 2038
    Teva agrees with Axsome to keep generic off market until 2038

    11 Feb 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/axsome-shares-jump-21-settlement-teva-will-keep-auvelity-generic-market-until-2038

    FIERCE PHARMA
    11 Feb 2025
    Share Share